Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-Op Pain in Distal Radius Surgery
NCT04540848Phase 4Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Mar 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by UTHealth Houston. Primary endpoint: Pain as measured by the Revised American Pain Society Patient Outcome Questionnaire (APS-POQ-R) at 24 hours. Planned start Mar 2021; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04540848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04540848.